---
figid: PMC3208056__nihms311981f4
figlink: /pmc/articles/PMC3208056/figure/F4/
number: F4
caption: APC gene or activating mutations in β-catenin, result in the accumulation
  of β-catenin and subsequent complex formation with TCF/LEF transcription factors.
  Excessive β-catenin can interact with TCF to activate transcription of proliferating
  genes, such as c-Myc and cyclin D1, in the colon. Inflammatory cytokines activate
  NF-κB by releasing p65, which is then translocalized to the nucleus, leading to
  increased transcription of target genes, such as iNOS, COX-2, TNF-α interleukins,
  and cyclin D1. Atorvastatin, in combination with sulindac or naproxen, targets the
  NF-κB and βcatenin/Wnt pathways and inhibits downstream signaling, iNOS, COX-2,
  cyclin D1 and others.
pmcid: PMC3208056
papertitle: Combination of atorvastatin with sulindac or naproxen profoundly inhibits
  colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway
  in rats.
reftext: Nanjoo Suh, et al. Cancer Prev Res (Phila). ;4(11):1895-1902.
pmc_ranked_result_index: '43747'
pathway_score: 0.932645
filename: nihms311981f4.jpg
figtitle: Combination of atorvastatin with sulindac or naproxen profoundly inhibits
  colonic adenocarcinomas by suppressing the p65/Beta-catenin/cyclin D1 signaling
  pathway in rats
year: ''
organisms:
- Homo sapiens
ndex: db6d1412-df09-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3208056__nihms311981f4.html
  '@type': Dataset
  description: APC gene or activating mutations in β-catenin, result in the accumulation
    of β-catenin and subsequent complex formation with TCF/LEF transcription factors.
    Excessive β-catenin can interact with TCF to activate transcription of proliferating
    genes, such as c-Myc and cyclin D1, in the colon. Inflammatory cytokines activate
    NF-κB by releasing p65, which is then translocalized to the nucleus, leading to
    increased transcription of target genes, such as iNOS, COX-2, TNF-α interleukins,
    and cyclin D1. Atorvastatin, in combination with sulindac or naproxen, targets
    the NF-κB and βcatenin/Wnt pathways and inhibits downstream signaling, iNOS, COX-2,
    cyclin D1 and others.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT2
  - MYC
  - WNT4
  - TNF
  - WNT8A
  - WNT3A
  - BCL2
  - WNT11
  - WNT1
  - WNT16
  - WNT10B
  - WNT2B
  - CTNNB1
  - NFKB1
  - WNT8B
  - APC
  - WNT5A
  - WNT6
  - WNT9A
  - WNT7B
  - WNT9B
  - WNT7A
  - WNT3
  - WNT10A
  - WNT5B
  - naproxen
  - sulindac
  - Cancer
genes:
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2
  entrez: '7472'
- word: c-myc)
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT4
  entrez: '54361'
- word: TNFA,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8A
  entrez: '7478'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: (Bcl-2)
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT11
  entrez: '7481'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT1
  entrez: '7471'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT16
  entrez: '51384'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10B
  entrez: '7480'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT2B
  entrez: '7482'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT8B
  entrez: '7479'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT6
  entrez: '7475'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9A
  entrez: '7483'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7B
  entrez: '7477'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT9B
  entrez: '7484'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT7A
  entrez: '7476'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT3
  entrez: '7473'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT10A
  entrez: '80326'
- word: Wnt
  symbol: WNT
  source: bioentities_symbol
  hgnc_symbol: WNT5B
  entrez: '81029'
chemicals:
- word: naproxen
  source: MESH
  identifier: D009288
- word: sulindac
  source: MESH
  identifier: D013467
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC3208056__F4
redirect_from: /figures/PMC3208056__F4
figtype: Figure
---
